While I realize the expertise of many of the posters exceeds mine ( I am learning..for info I go to StockCharts.com) I think the technicals on this stock, which I understand are very impressive, still are not the last word. We are dealing with opiates here and while the tamper-resistant idea is brilliant there still may be some DEA bureaucrats who won't like the resurgence of opiate-based drugs at all. They may worry about some criminals cracking the code, so to speak , and learning how to free the opiate from its chemical matrix. Other than that I agree that the going looks good. See http://ciitn.missouri.edu/testsite/www/2003005/group3_article.html for info on this if you wish.